Related Experiment Video
Updated: Aug 17, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Selective treatment for heart failure: the future beckons?
1Department of Cardiology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Abstract:
Myocardial failure results from a variety of insults yet treatments have been given in a nonselective way. The benefits of treatments on symptoms are not related to etiology, but there is increasing evidence that prognosis is. Whenever the prognostic benefits of treatments have been classified according to etiology, patients with myocardial damage without concomitant ischemic heart disease fare better. In this paper, we present and evaluate the data on prognosis and discuss the possible reasons behind these differences. These differences are important because they will help to inform patients and physicians about prognosis based on the underlying cause of myocardial damage. In the future, treatment may be more successful if it is targeted to patients according to the cause of heart failure.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions

